MENU
+Compare
BDTX
Stock ticker: NASDAQ
AS OF
Jul 3, 10:51 AM (EDT)
Price
$2.63
Change
+$0.03 (+1.15%)
Capitalization
141.02M

BDTX Black Diamond Therapeutics Forecast, Technical & Fundamental Analysis

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer... Show more

BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BDTX with price predictions
Jul 02, 2025

Aroon Indicator for BDTX shows an upward move is likely

BDTX's Aroon Indicator triggered a bullish signal on July 02, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 134 similar instances where the Aroon Indicator showed a similar pattern. In of the 134 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 52 cases where BDTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 30, 2025. You may want to consider a long position or call options on BDTX as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BDTX advanced for three days, in of 240 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BDTX moved out of overbought territory on June 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for BDTX turned negative on June 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BDTX broke above its upper Bollinger Band on June 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BDTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.045) is normal, around the industry mean (16.522). P/E Ratio (43.333) is within average values for comparable stocks, (58.479). BDTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (2.098) is also within normal values, averaging (261.553).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BDTX is expected to report earnings to fall 127.30% to -26 cents per share on August 12

Black Diamond Therapeutics BDTX Stock Earnings Reports
Q2'25
Est.
$-0.27
Q1'25
Beat
by $0.93
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.03
The last earnings report on May 13 showed earnings per share of 98 cents, beating the estimate of 5 cents. With 45.66K shares outstanding, the current market capitalization sits at 141.02M.
A.I. Advisor
published General Information

General Information

a biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 252-0848
Employees
54
Web
https://www.blackdiamondtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AERG2.230.05
+2.29%
Applied Energetics, Inc.
MSVB16.24N/A
N/A
Mid-Southern Bancorp, Inc.
FSNUF50.29N/A
N/A
Fresenius SE & Co. KGaA
NWSGY9.17N/A
N/A
CTF Services Limited
SKVI0.27N/A
N/A
Skinvisible, Inc.

BDTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
+4.84%
CCCC - BDTX
50%
Loosely correlated
+0.66%
ATXS - BDTX
49%
Loosely correlated
+5.52%
BEAM - BDTX
47%
Loosely correlated
+13.46%
RLAY - BDTX
47%
Loosely correlated
+2.27%
IMNM - BDTX
47%
Loosely correlated
+1.95%
More